BSTC Key Statistics, Chart & Performance
The current stock price of BSTC is 88.53 null. In the past month the price increased by 0.4%. In the past year, price increased by 59.92%.
BSTC Latest News, Press Relases and Analysis
About BSTC
Company Profile
BIOSPECIFICS TECHNOLOGIES is engaged in the business of producing and licensing, for sale by other, a U.S. Food and Drug Administration (``FDA``) approved enzyme derived from collagenase, named Collagenase ABC, and researching, developing and clinically testing additional products derived therefrom for potential use as pharmaceuticals.
Company Info
Biospecifics Tech Cp
2 Righter Parkway Suite 200
Wilmington DE 19803
CEO: J. Kevin Buchi
Phone: 302-842-8450
Biospecifics Tech Cp / BSTC FAQ
What does Biospecifics Tech Cp do?
BIOSPECIFICS TECHNOLOGIES is engaged in the business of producing and licensing, for sale by other, a U.S. Food and Drug Administration (``FDA``) approved enzyme derived from collagenase, named Collagenase ABC, and researching, developing and clinically testing additional products derived therefrom for potential use as pharmaceuticals.
Can you provide the latest stock price for Biospecifics Tech Cp?
The current stock price of BSTC is 88.53 null. The price increased by 0.15% in the last trading session.
Does Biospecifics Tech Cp pay dividends?
BSTC does not pay a dividend.
How is the ChartMill rating for Biospecifics Tech Cp?
BSTC has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
What is Biospecifics Tech Cp worth?
Biospecifics Tech Cp (BSTC) has a market capitalization of 650.25M null. This makes BSTC a Small Cap stock.
BSTC Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to BSTC. When comparing the yearly performance of all stocks, BSTC is one of the better performing stocks in the market, outperforming 90.02% of all stocks.
BSTC Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to BSTC. BSTC has an excellent financial health rating, but there are some minor concerns on its profitability.
BSTC Financial Highlights
Over the last trailing twelve months BSTC reported a non-GAAP Earnings per Share(EPS) of 2.61. The EPS decreased by -17.41% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 47.43% | ||
| ROA | 12.64% | ||
| ROE | 12.83% | ||
| Debt/Equity | 0 |